In addition, hepatitis B surface antigen-specific CD4+ T cells showed significantly less proliferation in PBMCs of high-risk obesity NAFLD patients compared to that in low-risk obesity NAFLD subjects. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.